D-MANOZINN®

Urine volume and “good” bacteria normally living in urinary tract most frequently prevent bacterium E. coli from developing.

In cases when urine volume is insufficient – in case of dehydration or when the bladder is pressed or crushed as in the case of pregnancy, urine will be kept for too long giving a chance to bacteria to develop, causing thus the irritation and inflammation.

The bacteria that most commonly leads to inflammation of the bladder and urinary tract infection is the bacterium E. coli. This bacterium has finger-like extensions, fimbriae, at its surface which it uses to bind to the urinary tract wall in humans starting thus the infection.

PHASE 1: Bladder infection is usually caused by the bacterium E. coli that comes from the digestive tract.

PHASE 2: The protective layer covering (protecting) the cell lining of the bladder is made up of molecular structure, which includes a large number of sugar molecules (endogenous d-mannose). The bacterium E. coli (which nevertheless loves sugar) primarily binds to these molecules, after which the inflammation process starts which sets our immune system in motion.

PHASE 3: Administering D-MANOZINN® will enable the presence of greater quantities of d-mannose molecules in urine. D-mannose is extremely poorly metabolized, therefore most of the administered d-mannose is excreted in urine unchanged.

PHASE  4: D-mannose binds to (gets attached to) fimbriae (small extensions) of bacteria which leads to inflammation (90% E. coli). D-mannose thus prevents bacteria from binding to the wall of our urinary tract and enables easy and fast elimination of bacteria (their washing down) into the environment via urine.